Lilly $LLY, obezite ilaçları geliştirmek için Superluminal ile 1.3 milyar dolarlık anlaşma imzaladı.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.